Skip to content

Public FDA record

Z-2584-2024: Cepheid, Sample Collection Device, Part: 900-0370

Recall record Z-2584-2024 for Cepheid. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2584-2024
Company in FDA record
Cepheid
FDA classification date
Aug 14, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Specimen collection device may leak after the patient sample swabs have been inserted into the test tubes, which could result in biohazard exposure, cross contamination causing false positive results for other specimens, and/or delay to test results.

Source facts

Action
On 6/20/24, "Urgent Medical Device Recall" notices dated 6/18/24 were sent to customers describing the product, problem and actions to taken. The notices informed them of the following: 1) Dispose of Collection/affected Devices from Copan lots you may currently have in use or in your inventory. 2) The quality issue with the Collection Device is intermittent, so the firm asks that if you receive a positive or negative test result, to please follow the Instructions for Use (IFU) for your specific assay, and your facility's protocol related to management of test results. 3) Share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product(s) listed above to another laboratory, please provide them a copy of this letter. 4) Complete and return the response via email to here: https://iqvia-response.my.site.com/mt/fca?cid=24far007 Firm is investigating the root cause of the reported leaking issue and working with the supplier to avoid recurrence in the future. For recall response support contact the firm at +1 844 920 1427 cepheidrecall-24far007@iqvia.com Outside the US phone +44 808 178 5381 Technical Support/Region/Country/Telephone/Email U.S./+1 888 838 3222, option 2/techsupport@cepheid.com; Latin America/N/A/latamsupport@cepheid.com; France/+ 33 563 825 319/support@cepheideurope.com; Germany/+ 49 21 514 474 524/support@cepheideurope.com; Portugal/+ 351 800 913 174/support@cepheideurope.com; Spain/+ 34 919 906 762/support@cepheideurope.com; Other European Countries/+ 33 563 825 319/support@cepheideurope.com; Hong Kong/N/A/techsupportapac@cepheid.com; Middle East and African Countries/+ 971 4 550 8617/support@cepheideurope.com; Other Countries Not Listed/+ 1 408 400 8495/techsupport@cepheid.com
Initiated
2024-06-20
Root cause
Under Investigation by firm
Distribution
Worldwide distribution: US (nationwide): IL, TX, OH, LA, NY, CA, MD, IA, MN, KY, NH, WI, MO, NC, UT, WA, FL, NJ, SC, CO, PA, SD, NE, MT, WV, GA, MA, RI, CT, DE, MS, OK, VA, ID, AZ, OR, MI, IN, TN, AL, KS, ME, AR, NV, HI, AK, NM, WY, VT, ND, DC OUS (foreign) to countries of: Chile, Ireland, Oman, Nicaragua, Germany, San Marino, Ecuador, New Caledonia, France, Austria, United Kingdom, Finland, Italy, Hong Kong, Kuwait, United Arab Emirates, Netherlands, Belgium, Monaco, Colombia, Spain, Portugal, Poland, Switzerland, Denmark, Jersey, Mexico
Recall number
Z-2584-2024
Recall status
Open, Classified
CDRH record ID
208841
FDA classified
2024-08-14
Recall event number
94932

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗